Adama and BASF sign agreement on flumethylsulforim fungicide in Europe.

Adama Ltd. and BASF announced a strategic co-development and commercialization agreement focused on a fungicidal active ingredient. Gilboa (flumethylsulforim), owned by Adama. The partnership seeks to accelerate the delivery of new disease management solutions to European farmers, in a context of increasing resistance and the withdrawal of active ingredients from the market.

Under the agreement, BASF will develop and market new formulations based on Gilboa, in parallel with Adama's own products. Each company will independently define concepts, pricing, sales, and market access strategies. The cooperation combines Adama's innovation capacity and expertise in mixtures with BASF's strength in development and market access.

Flumethylsulforim presents a novel mode of action for cereals and is part of FRAC Group 32, linked to nucleic acid metabolism, recognized this year. The ingredient functions as a platform for broad-spectrum, long-lasting solutions in disease control, focusing on protecting productivity and quality.

According to Florian Wagner, executive vice president of portfolio and innovation at Adama, European producers demand reliable and resilient protection against various diseases. He stated that BASF was chosen because of the convergence in innovation, quality, and sustainability, with the goal of bringing the technology to the field more quickly.

Marko Grozdanovic, Senior Vice President of Global Strategic Marketing at BASF Agricultural Solutions, highlighted the history of cooperation between the companies and the combination of BASF's fungicide portfolio and market knowledge with Adama's active ingredient and product expertise.

Subject to regulatory approvals, the companies plan to launch flumethylsulforim-based formulations for wheat in Great Britain in 2027, with expansion into other European markets in 2029.